Physician profile
Mark Kahn
NPI 1003863937
$5,724.48
in general payments reported to CMS, 2019-2025
21 companies · $21.85 in 2025
The $21.85 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $581 · 2021: $703 · 2022: $1,433 · 2023: $1,608 · 2024: $230 · 2025: $21.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122 · Travel and Lodging: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.60 |
| Travel and Lodging | $738.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,038.51 | 2021-2024 | Endurant Iis |
| Abbott Laboratories | $946.09 | 2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $886.05 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $578.70 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic Vascular, INC. | $555.15 | 2019-2020 | |
| Inari Medical, INC. | $240.47 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Endologix LLC | $238.99 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $221.40 | 2020 | |
| Kci USA, INC. | $213.08 | 2020-2021 | |
| Stryker Corporation | $166.09 | 2021-2022 | |
| Penumbra, INC. | $153.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $143.44 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $121.98 | 2019-2023 | Sternalock Blu System |
| Triad Life Sciences INC. | $60.60 | 2022 | |
| Edwards Lifesciences Corporation | $41.46 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $31.88 | 2021-2022 | |
| Viiv Healthcare Company | $24.25 | 2019 | |
| Bard Access Systems, INC. | $19.93 | 2019 | |
| Baxter Healthcare | $15.78 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.95 | 2019 | |
| Integra Lifesciences Corporation | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.